Co-managing partner Phil Colburn has transformed Cantor Colburn into one of the nation’s leading intellectual property law firms. Phil leads a team of more than 110 attorneys, patent agents, and technical advisors who are committed to helping clients optimize their IP assets through the timely delivery of top quality, cost-effective legal services.
His counsel to Fortune 50 multinationals, as well as smaller companies and universities, is informed both by unique technical insights gained from his years of professional experience as a design engineer and by strategic perspectives derived from more than 20 years’ practice as an IP attorney. Taking a proactive, results-driven approach allows him to help clients define their needs and implement strategies that achieve their objectives. A frequent speaker on IP issues, Phil is an Adjunct Professor of Patent Law at Western New England College School of Law.
Martha Rockwood is Senior IP Counsel at Cognex Corporation in Natick. Cognex is the global leader in vision-based inspection, guidance and identification systems that give machines the power to “see.” Martha manages Cognex’s US and international patent and trademark portfolios, as well as provides strategic IP advice and litigation support to Cognex business groups. Prior to coming to Cognex, Martha worked at Proskauer LLP in the IP and Litigation Department. She has a B.S. and M.S. in Physics from Boston College and a J.D. from Boston College Law School.
Catherine Feldman manages and advises on intellectual property matters for Philips' Ultrasound and Image Guided Therapy businesses. Her experience includes patent strategy development and implementation, patent prosecution, IP litigation, risk assessments, due diligence, and branding. Prior to joining Philips, Catherine practiced at a Boston law firm focusing on a variety of technologies. These included medical devices, imaging, life sciences, software, and consumer goods.
Michael Bunis, co-chair of the firm's Intellectual Property Litigation Practice Group, is a leading litigator with more than 20 years of experience representing technology and life sciences companies in high stakes litigation and other complex IP related disputes. He has been recognized by The Legal 500, Best Lawyers in America and as a Massachusetts Super Lawyer. Mr. Bunis is a member of the firm’s Executive Committee.
Lisa Geller is Head of Intellectual Property at Seres Therapeutics, Inc., a clinical stage company developing microbiome therapeutics. Her skills and background include experience in all aspects of transactional intellectual property law particularly in areas related to biotechnology and pharmaceuticals. Dr. Geller has worked in-house with large and small public companies as well as start-ups. She practices an integrated approach to intellectual property portfolio management, working closely with business, R&D, CMC, and clinical to achieve company goals.
Dr. Geller began her legal career at Fish & Richardson and was counsel at Wilmer Hale. Her Ph.D. in biology is from the University of California, Los Angeles and her J.D. from Boston University School of Law where she is an adjunct professor teaching patent prosecution. Dr. Geller is also a long-time member of the Genetics and Society Working Group and is on the editorial board of Science and Engineering Ethics.
Philip is a Director and Senior IP Counsel at Boehringer Ingelheim USA Corporation located in Ridgefield, Connecticut. In his 15 years as IP counsel for Boehringer, Phil has drafted and prosecuted patent applications and strategically managed patent portfolios in a number of therapeutic areas; conducted patentability and freedom to operate assessments; supported NDA filings with regulatory exclusivity requests and patent information; performed IP due diligence reviews in connection with in-licensing of early to late stage products; negotiated IP provisions in various types of agreements; assisted in developing best practices for IP protection and for the negotiation of IP provisions in agreements; and has counseled on US export compliance issues and the development of related internal policies and procedures. Prior to joining Boehringer, Phil was an associate attorney at the Sughrue, Mion law firm in Washington, D.C., and prior to his tenure at Sughrue, Phil was a patent examiner at the U.S. Patent and Trademark Office. Phil has a Bachelor of Science in organic chemistry from the University of Maryland, and a law degree from the George Mason University School of Law and is a regular speaker on various IP, patent and export compliance topics.
James’ practice includes patent procurement, opinion, analysis & strategy, litigation, technology licensing, primarily focusing on life sciences, material sciences, medical device, and electronics. As a conduit between China and the rest of the world, James represents international clients to obtain and enforce their intellectual property (IP) rights in the fast-evolving and challenging IP environment in China. In particular, James helps international clients to enhance the value of IP assets, lower IP risks, and increase commercialization opportunities through comprehensive due diligence, counseling, procurement, litigation and cross-border licensing and collaboration.
Ron is the chief legal contact for Gillette Venus, a global $1 billion dollar business and has a dual role as lead patent counsel for the Gillette chemistry organization. In these roles, Ron blends technical capability with understanding of global CPG manufacturing industries to provide actionable legal guidance for senior commercial and technical management. Ron also handles talent and sponsorship deals for ~ 20 of P&G’s billion dollar brands. Before relocating to Boston, Ron supported P&G’s global Fabric and Home Care businesses as a patent attorney. Prior to pursuing a career in law, Ron worked several years in the New York area as a management consultant for Accenture. Ron has a B.S. in Chemical Engineering from Tufts University in MA and a J.D. from UNH School of Law (formerly Franklin Pierce Law Center.)
James Markarian is Senior Counsel and Licensing Manager for North America for Siemens Corporation. He manages Siemens' outbound licensing programs and IP sales; handles incoming licensing matters and IP acquisitions; and negotiates and drafts various transactional agreements (e.g., IP licenses, JV's, Software licenses, R&D's, Agent and Service, Asset Purchase or Sale, NDA's, etc.). James provides support for Siemens' M&A activities, advises Siemens' business units regarding IP asset management as well as IP issues related to standards organizations. He has an Aerospace Engineering degree from Boston University and a JD degree from Brooklyn Law School. Before joining Siemens, he worked for Refac Corporation, and the law firms of Pennie & Edmonds; Ladas & Parry; and, Wyatt, Gerber, Burke & Badie.
Tom Brown is intellectual property litigation attorney at Dell with substantial experience in high-stakes cases representing both plaintiffs and defendants, with particular emphasis on patent litigation. Prior to the Dell - EMC merger, Tom managed EMC's patent litigations and IPR proceedings, including in the district court, on appeal, and in the PTAB; worked on legislative patent policy issues; supervised amicus briefs filed in the Federal Circuit and Supreme Court.
Prior to Dell/EMC, Tom held a Principal role at Fish and Richardson P.C. He clerked for the Hon. Robert E. Keeton (US District Court) and was a Software Design Engineer at Microsoft. Tom earned his B.S. Computer Science & Political Science, Yale University and his J.D. from Harvard Law School.
Companies and individuals work hard to create business opportunities to build on a successful business. Understanding this, Ross helps them protect their business and realize the gains of their efforts by developing the proper IP strategy. “It’s important to understand the goals of each business, and focus the business’ IP strategy in a direction that helps meet those goals,” Ross says. “When I’m advising larger financial services or medical device clients, I have a different approach than, say, smaller tech startups.”
In successfully prosecuting utility patent applications, design patent applications, and trademark applications for his clients, Ross has gained valuable experience in both foreign and domestic prosecution. After the patents or trademarks have been obtained, Ross also works with clients to develop the proper licensing or litigation strategy for protecting their rights. In fact, Ross has spent nearly 10 years supporting litigation and licensing efforts.
Ross has valuable experience formulating and executing post-grant strategy on behalf of his clients as well. “Due to your limited opportunity to convince an adverse party of your position, whether it be an Examiner in a reexam or a company in litigation, going in with the proper strategy is 90% of the battle,” Ross reminds his clients. “Preparing the proper initial strategy for success to drive the variables toward improving your position in litigation or licensing discussions is always fact intensive. You have to spend the right amount of time upfront.”
Ross understands the technological, legal, and business aspects of inventions that leverage electrical and computer systems. For example, he is familiar with computer hardware and software, mobile devices (e.g., apps, cell phones, tablets, etc.), medical devices, wired and wireless networking systems (e.g., Wi-Fi, Bluetooth, NFC, Zigbee, etc.), telecommunications systems, load control systems, and manufacturing systems. Having been exposed to a substantial breadth of industries, including financial services, software development, home automation, medical device, and telecommunications, Ross has the ability to tailor strategies to specific market segments.
Prior to practicing law, Ross worked as a software developer and technical support expert to learn the ins and outs of the technology he helps protect today. While in law school, Ross was an Executive Editor of the Syracuse Law Review and Associate Editor of the Syracuse Science and Technology Law Reporter.
Randy Morin serves as Vice President, Head of Intellectual Property at Translate Bio. He formerly served at Vertex Pharmaceuticals as Assistant Chief IP Counsel and at Shire Pharmaceuticals as Lead, Business Development Transactions and as Lead IP Attorney for Shire Research and Development. In his legal roles, Randy has supported R&D, Business Development and Commercial organizations in various capacities, including patent strategy, diligence, prosecution, litigation, deal strategy and negotiations.
Atabak Royaee is an Associate Director and Corporate Counsel, IP, at Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) located in Ridgefield, Connecticut. In his role at Boehringer, Atabak manages BIPI’s patent portfolios in various therapeutic areas, drafts and prosecutes patent applications, drafts legal opinions, assist in handling IPR proceedings, performs due diligence reviews, and provides counsel to business on licensing and transactional matters. Prior to joining BI, Atabak was an associate attorney at McDermott Will & Emery and LeClairRyan law firms conducting patent prosecution and post-grant proceedings work; and prior to his tenure at law firms, Atabak was a postdoctoral fellow at Harvard School of Public Health and U.S. Department of Agriculture specializing in immunology and infectious disease research. Atabak has B.S. in chemistry and a Ph.D. in biochemistry and molecular biology from Georgetown University, and a law degree from the Suffolk University Law School.
Dr. Fangli Chen is a partner in the Litigation Department and vice chair of the Life Sciences Patent practice. Dr. Chen represents all types of companies in the biotech and pharmaceutical industries, and has deep scientific expertise and a strong business sense. She effectively identifies and transforms technological developments into valuable intellectual property assets for her clients and specializes in the strategic development of complex IP portfolios for companies that align with their business goals. The primary focus of her practice is intellectual property prosecution, which includes strategic development of complex patent portfolios for companies, universities and research institutions. She prepares and prosecutes patent applications in the fields of biochemistry, molecular and cell biology, immunology, biochemical and molecular diagnostics, pharmaceuticals, microbiology, molecular genetics, pharmacogenomics, recombinant technologies, enzyme replacement therapy, messenger RNA therapy, gene therapy, bioinformatics, drug discovery, medical devices and chemistry; performs due diligence investigations, and provides freedom-to-operate studies, non-infringement and invalidity analysis.
Ed Black is co-head of Ropes & Gray's intellectual property transactions and technology, media & telecommunications practice groups. He is a corporate and intellectual property attorney who represents companies operating in the fields of technology, media, telecom, investment management, and consumer branded products in both the management of strategic intangible assets, and transactions related to strategic intangible assets. These transactions include mergers, acquisitions, asset transactions, joint ventures and alliances, collaborations, licensing and other arrangements. Ed's clients include hedge funds, technology companies, branded product companies, health care management organizations, financial services companies, media organizations and private equity investors. Ed remains active with many trade and professional associations where he is a frequent speaker on intellectual property, media, technology, and the operation of businesses utilizing intangible assets and proprietary rights.
Christopher Carroll is an Intellectual Property partner based in the Firm's Boston office, with a dual practice in London. He concentrates his practice on providing strategic patent advocacy and is licensed to practice before the US Patent and Trademark Office (USPTO), the European Patent Office (EPO) and the UK High Court. He provides advice and develops strategies for clients on patents, trademarks and copyrights.
Christopher's engineering background enables him to focus on the areas of mechanical, electrical, software and communications engineering including wireless protocols, Internet protocols and information security. His clients include software, telecommunications, medical and Internet companies.
Christopher's experience involves drafting and prosecuting U.S. and foreign patent applications and advising on patent portfolios for clients located all over the world. He regularly prepares legal opinions regarding patent validity, infringement and freedom-to-operate, provided due diligence opinions related to intellectual property, and drafted technology-related license agreements. He also has extensive experience handling Opposition and Appeal proceedings at the European Patent Office.
Prior to joining White & Case, Christopher was Counsel at an international law firm. In his earlier career prior to attending law school, Christopher supervised research related to wireless communications network security at Verizon and GTE Laboratories. He also developed Mobile IP cryptographic key distribution procedure used by Verizon Wireless in its 3G data service. His background also encompasses service in the U.S. Navy Submarine Force as a nuclear reactor operator. Christopher is an inventor of eight U.S. patents related to wireless security.
Reza Mollaaghababa, Ph.D. is a partner in the Intellectual Property Department of Pepper Hamilton LLP, resident in the Boston office. Dr. Mollaaghababa is co-chair of the firm’s Intellectual Property Transactions and Rights Management Practice Group.
Dr. Mollaaghababa’s practice focuses on all aspects of intellectual property law, including preparation and prosecution of patent and trademark applications, preparation of patentability, infringement, validity and clearance opinions. He has prepared and prosecuted patent applications in diverse fields of technology, such as photonics/optics, nanotechnology, medical devices, semiconductor processing, lithography, telecommunications, magnetic resonance, and computer hardware and software.
Dr. Mollaaghababa works with well-established companies, emerging companies as well as academic institutions to identify and protect their intellectual property. He provides clients with strategic counseling, including licensing as well as formation and management of intellectual property portfolios.
Dr. Mollaaghababa also represents clients in post-grant proceedings before the U.S. Patent Office. He has handled more than 40 inter partes review (IPR) proceedings. He is a co-founder and frequent contributor of a blog on post-grant issues: www.postgrant-counsel.com.
Before joining Pepper, Dr. Mollaaghababa was a partner with Nutter McClennen & Fish LLP in Boston, where he was chair of the firm’s Diversity Committee.
Current Account Executive for Questel, a leading provider of online tools and services helping businesses, academic institutions, technology transfer offices, and law firms with their patent research and IP strategy needs. Results driven individual with a track record of growing my client network, increasing portfolio revenue, maintaining strong relationships with clients, and providing unmatched customer service.
Ron Cahill is a partner at Nutter McClennen & Fish LLP where he chairs the Firm’s Intellectual Property Litigation Practice Group. Ron works with clients of all sizes to solve their most challenging intellectual property problems. While much of his work involves presenting his clients’ cases to judges and juries around the country, many clients ask him to apply that experience to strategic planning within their businesses and especially with respect to their competitors or potential deal partners.
Ron’s most recent experience includes leading trial teams in busy patent courts in Delaware and California on behalf of defendants in competitor patent infringement suits. As these cases involve multiple jury trials as well as multiple concurrent IPR and reexamination proceedings, they also spawn numerous trips to the Court of Appeals for the Federal Circuit.
For his work in IP litigation, Ron has been recognized by The Best Lawyers in America, IP Stars, and Super Lawyers.
Shayne Phillips has been working in the intellectual property (IP) arena for over fifteen years, particularly in the areas of IP-related competitive intelligence and technical patent and nonpatent literature searching. Ms. Phillips began her career at Procter & Gamble (P&G) in Cincinnati, Ohio, working as a Technical Assistant in Corporate New Ventures (a group tasked with evaluating outside technology for the entirety of P&G). She then moved to the IP-practice group of Dinsmore & Shohl (also in Cincinnati), working as a Technical Consultant, providing both patent application prosecution support and IP litigation assistance. In 2000 Ms. Phillips moved to Columbus, Ohio, and began work at Chemical Abstracts Service (CAS) as an Editorial Analyst in the Mammalian Hormones Document Indexing Group of the Biochemistry Department of CAS’ Editorial Division. In 2002 she transitioned to the role of Applications Specialist at CAS, specializing in advanced STN training, focusing on protein and gene sequence searching in particular. Following her tenure at CAS, Ms. Phillips moved to Halliburton in Houston, Texas, working in their Intellectual Asset Management group as both the head of IP Competitive Intelligence and as a Senior Patent Liaison for the Cementing and Multichem Product Service Lines. Ms. Phillips holds a Bachelor of Science degree in Biology from Youngstown State University, a Master of Science degree in Biochemistry from the University of Cincinnati, and a Master of Business Administration degree from Capital University in Columbus, Ohio. She is also a registered US Patent Agent.